Home Tags Phil Morle

Tag: Phil Morle

LawPath ‘the Xero of legal’ has raised $1.3 million from a bunch of interesting...

LawPath ‘the Xero of legal’ has raised $1.3 million from investors who have previously spotted hot Aussie tech start-ups Canva, Temple & Webster, Ansarada.

Pollenizer raises $1.1 million, eyes expansion in South East Asia

“This latest round of capital shows Australian investors are beginning to realise what global investors have known for some time, that Australian technology startups offer high investment value,” said Pollenizer CEO Phil Morle.

Seeking intelligence on digital startups, Mi9 joins hands with Pollenizer

Mi9’s Product Innovation team would drive this partnership and has the “remit to grow the group’s ventures portfolio.” Part of this process would involve sifting through Pollenizer’s startups and accelerating those with new digital products. Mi9 also will have the option to invest in these new digital businesses.

More want to watch Pygg grow fatter

Pygg’s stock is rising. The Australian-born Twitter payment pioneer has banked $600,000 in new angel capital. Pollenizer, the startup incubator, raised most of the amount from a bunch of new and previous investors.
Subscribe to the Newsletter Over 30K subscribers

FREE BUSINESS TOOLS

How to build a retail empire with James Webber [FREE REPORT]

Starting any new business is hard, but starting an online retail business is particularly hard. You see, this is one industry that combines technology, logistics and, of course, marketing – it’s a juggling act. To help us crack this hard nut, we sought the wisdom James Webber, CEO at Bookworld.

FREE BUSINESS TOOL

The Alchemy of Negotiation with Matt Lohmeyer [FREE REPORT]

Negotiation is part and parcel of everyday life. Despite this, the idea of honing our negotiating skills doesn’t go down well with most of us. We fear that we’ll end up being manipulative, exploitative, scheming. To help us break the chains of this retrogressive mentality, we have Matt Lohmeyer. He has worked as a professional negotiator in various fields for over eight years and before that, negotiated deals with biotech pharmaceutical and chemical companies. In short, he’s an Alchemist in the Art of Negotiation.

INFOGRAPHICS

New Zealand’s Xero eyes US IPO, further disruption as subscribers increase...

Xero recently held its annual meeting in Wellington, during which the company revealed some interesting details about its future. As has been widely suspected, the...

OPINIONS & ADVICE